MDK and neoplasm: Transcriptomic and proteomic analyses from large-scale datasets such as TCGA and CPTAC have demonstrated that MDK is consistently overexpressed in aggressive tumor types, including hepatocellular carcinoma, lung adenocarcinoma, and ovarian cancer.